The New Penicillin? Pharmacotherapy for Obesity

Join Drs Nihar Desai and Neda Rasouli as they discuss the evolution of obesity treatment over the past two decades, including the latest novel therapies.
Relevant disclosures can be found with the episode show notes on Medscape www.medscape.c.... The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A State-of-the-Art Review pubmed.ncbi.nl...
Obesity emedicine.meds...
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association pubmed.ncbi.nl...
Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023 www.cdc.gov/nc...
Physiology, Obesity Neurohormonal Appetite and Satiety Control www.ncbi.nlm.n...
Melanocortin-4 Receptor Complexity in Energy Homeostasis, Obesity and Drug Development Strategies pubmed.ncbi.nl...
Bariatric Surgery emedicine.meds...
The Effects of Bariatric Surgery on Cardiovascular Outcomes and Cardiovascular Mortality: A Systematic Review and Meta-Analysis pubmed.ncbi.nl...
Semaglutide and Cardiovascular Outcomes in Obesity Without Diabetes pubmed.ncbi.nl...
Comparison of Tirzepatide and Dulaglutide on Major Adverse Cardiovascular Events in Participants With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: SURPASS-CVOT Design and Baseline Characteristics pubmed.ncbi.nl...
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO) clinicaltrials...
Effects of Semaglutide on Chronic Kidney Disease in Patients With Type 2 Diabetes pubmed.ncbi.nl...